glutamic acid has been researched along with piperazine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Grover, LM; Teyler, TJ | 1 |
Ahring, PK; Gajhede, M; Hald, H; Kastrup, JS; Liljefors, T; Timmermann, DB | 1 |
Hao, M; Li, G; Li, Y; Wang, Y; Yan, Y; Yang, L; Zhang, S | 1 |
4 other study(ies) available for glutamic acid and piperazine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Different mechanisms may be required for maintenance of NMDA receptor-dependent and independent forms of long-term potentiation.
Topics: Action Potentials; Animals; Calcium; Glutamic Acid; Hippocampus; Long-Term Potentiation; Neural Pathways; Piperazine; Piperazines; Protein Kinases; Receptors, N-Methyl-D-Aspartate | 1995 |
Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.
Topics: Allosteric Regulation; Animals; Antihypertensive Agents; Benzothiadiazines; CHO Cells; Cricetinae; Cricetulus; Crystallography, X-Ray; Dimerization; Glutamic Acid; Models, Molecular; Molecular Sequence Data; Molecular Structure; Patch-Clamp Techniques; Piperazine; Piperazines; Protein Structure, Quaternary; Rats; Receptors, AMPA | 2009 |
Combined 3D-QSAR, molecular docking, and molecular dynamics study on piperazinyl-glutamate-pyridines/pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.
Topics: Biological Availability; Glutamic Acid; Heterocyclic Compounds, 1-Ring; Humans; Molecular Dynamics Simulation; Piperazine; Piperazines; Platelet Aggregation; Protein Conformation; Purinergic P2Y Receptor Antagonists; Pyridines; Pyrimidines; Quantitative Structure-Activity Relationship; Receptors, Purinergic P2Y12; Reproducibility of Results | 2011 |